Methodology

All entries for: Telix Pharmaceuticals (US) Inc.

November 1, 2025

Telix Pharmaceuticals (US) Inc.

Orphan Drug Designation

FDA orphan drug designation: treatment of malignant glioma

Disease Area: Rare Diseases
Source
Source
Scroll to Top